Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 2, 2004, Pages 132-139

  Blomgren, J ^a,b,d   Ekman, B ^a   Andersson, P O ^b   Arnqvist, H J ^a,c  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Eksjö County Hospital   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d Medicinkliniken   (Sweden)

Author keywords

Control subjects; Cortisol; Cortisone acetate; Diurnal; Pituitary insufficieney; Substitution

Indexed keywords

CORTICOTROPIN; CORTISONE; CORTISONE ACETATE; GROWTH HORMONE; HYDROCORTISONE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOPHYSIS; PHYSIOLOGY; PRIORITY JOURNAL; SAMPLING;

ADULT; AGED; BODY WEIGHT; CORTISONE; FEMALE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; MALE; MIDDLE AGED; SEX CHARACTERISTICS; TIME FACTORS;

EID: 1842832941     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410004867     Document Type: Article

References (32)

1. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP. Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 1997; 46: 255-61.
2. Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 1994; 120: 207-10.
3. Orth DN, Island DP. Light synchronization of the circadian rhythm in plasma cortisol (17-OHCS) concentration in man. J Clin Endocrinol Metab 1969; 29: 479-86.
4. Udelsman R, Goldstein DS, Loriaux DL, Chrousos GP. Catecholamine- glucocorticoid interactions during surgical stress. J Surg Res 1987; 43: 539-45.
5. Brandenberger G, Follenius M, Wittersheim G, Salame P. Plasma catecholamines and pituitary adrenal hormones related to mental task demand under quiet and noise conditions. Biol Psychol 1980; 10: 239-52.
6. Cohen N, Gilbert R, Wirth A, Casley D, Jerums G. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease. J Clin Endocrinol Metab 1996; 81: 1411-5.
7. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001; 86: 2909-22.
8. Williams GH, Dluhy RG. Disorders of the adrenal cortex. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamesson JL, editors. Harrison's principles of internal medicine. 15th ed. USA: McGraw Hill; 2001. p. 2099
9. Melmed S. Disorders of the anterior pituitary and hypothalamus. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamesson JL. editors. Harrison's principles of internal medicine. 15th ed. USA: McGraw Hill; 2001. p. a2034.
10. Groves RW, Toms GC, Houghton BJ, Monson JP. Corticosteroid replacement therapy: twice or thrice daily? J R Soc Med 1988; 81: 514-6.
11. Howlett TA. An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1997; 46: 263-8.
12. Scott RS, Donald RA, Espiner EA. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy. Clin Endocrinol (Oxf) 1978; 9: 571-6.
13. Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf) 1981; 14: 451-8.
14. Weaver JU, Thaventhiran L, Noonan K, Burrin JM, Taylor NF, Norman MR, Monson JP. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol (Oxf) 1994; 41: 639-48.
15. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity. Clin Endocrinol (Oxf) 1998; 48: 153-62.
16. Toogood AA, Taylor NF, Shalet SM, Monson JP. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. J Clin Endocrinol Metab 2000; 85: 1727-30.
17. Kehlet H, Binder C, Blichert-Toft M. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin Endocrinol (Oxf) 1976; 5: 37-41.
18. Jenkins JS, Sampson PA. Conversion of cortisone to cortisol and prednisone to prednisolone. Br Med J 1967; 2: 205-7.
19. Colburn WA, DiSanto AR, Stubbs SS, Monovich RE, DeSante KA. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a single oral administration of cortisone acetate to human subjects. J Clin Pharmacol 1980; 20: 428-36.
20. Srivastava LS, Werk EE Jr, Thrasher K, Sholiton LJ, Kozera R, Nolten W, Knowles HC Jr. Plasma cortisone concentration as measured by radioimmunoassay. J Clin Endocrinol Metab 1973; 36: 937-43.
21. Turner AK, Carroll CJ, Pinkus JL, Charles D, Chattoraj SC. Simultaneous competitive protein binding assay for cortisol, cortisone, and prednisolone in plasma, and its clinical application. Clin Chem 1973; 19: 731-6.
22. Heazelwood VJ, Galligan JP, Cannell GR, Bochner F, Mortimer RH. Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. Br J Clin Pharmacol 1984; 17: 55-9.
23. Trainer PJ, McHardy KC, Harvey RD, Reid IW. Urinary free cortisol in the assessment of hydrocortisone replacement therapy. Horm Metab Res 1993; 25: 117-20.
24. Charmandari E. Is hydrocortisone clearance 50% slower in the evening than in the morning? J Clin Endocrinol Metab 2001; 86: 948-9.
25. Aanderud S, Myking OL. Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state. Acta Med Scand 1981; 210: 157-61.
26. Rodriguez-Arnao J, Perry L, Besser GM, Ross RJ. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 1996; 45: 33-7.
27. Tschop M, Lahner H, Feldmeier H, Grasberger H, Morrison KM, Janssen OE, Attanasio AF, Strasburger CJ. Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults. Eur J Endocrinol 2000; 143: 769-73.
28. Beentjes JA, Kerstens MN, Dullaart RP. Effects of growth hormone replacement on cortisol metabolism in hypopituitary patients treated with cortisone acetate. Scand J Clin Lab Invest 2001; 61: 277-86.
29. Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta 1987; 165: 379-85.
30. Weaver JU, Taylor NF, Monson JP, Wood PJ, Kelly WF. Sexual dimorphism in 11 beta hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin Endocrinol (Oxf) 1998; 49: 13-20.
31. Toogood AA, Taylor NF, Shalet SM, Monson JP. Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent. Clin Endocrinol (Oxf) 2000; 52: 61-6.
32. Born J, Spath-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989; 68: 904-11.